Related Experiment Video
Updated: Jul 20, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Growth hormone deficiency associated with moyamoya disease in a 16 year-old boy
Maria Kalina1, Barbara Kalina-Faska, Katarzyna Wojaczynska-Stanek
1Department of Pediatric Endocrinology and Diabetes, Medical University of Silesia, Katowice, Poland. majak_2001@yahoo.com
Abstract:
Moyamoya disease is a rare cerebrovascular disorder which, according to a few literature reports, can coexist with hypothalamic-pituitary dysfunction. We report a 16 year-old boy referred to our Department because of short stature and headaches. He additionally, at admission, presented discrete facial dysmorphy, bruxism, luxation of temporomandibular joint and cryptorchidism. The height was 146 cm (-4.3 SDS); the sexual development was P2G2A1 and the bone age 11.5 years. The intellectual development was normal. No focal neurological deficits were observed. Based on baseline and stimulated hormonal values, isolated growth hormone deficiency was diagnosed. Malformation of the cerebral vessel was suspected on magnetic resonance imaging and upon angiocomputed tomography and panangiography, a picture suggesting moyamoya disease was obtained. Growth hormone has been administered with daily injections at the dose of 0.025 mg/kg/24h, and the first year height velocity was 12 cm/yr. No adverse events resulting from the treatment have been noted so far. This case indicates that GH deficiency may be associated with moyamoya disease, possibly resulting from chronic cerebrovascular insufficiency.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Huntington Disease l: Introduction
Cushing Syndrome II: Pathophysiology
Mitral Valve Prolapse I: Introduction
Inborn Errors of Metabolism
Nature and Nurture

